Herantis Pharma published the Annual report for 2021
Herantis Pharma Plc Company release 23 Mar 2022 at 08:00 am EET Herantis Pharma Plc (“Herantis”), an innovative biotech company developing new disease modifying therapies for Parkinson’s disease, has today published the annual report for 2021. The Annual Report contains financial statements and the report of the Board of Directors. The Annual Report is available in PDF format in Finnish and English as appendices to this release and on Herantis Pharma’s website: https://herantis.com/investors/financial-reports/ For more information, please contact: Julie Silber/Gabriela Urquilla